Impressive results from J&J's vaccine candidate published in Nature. Challenge trial in rhesus macaques with arguably the most impressive results of any vaccine candidate. Effectively sterilizing immunity from a single dose. This one is a bit behind the front runners, with phase III expected to start in September.